Eden Research Share Discussion Threads

[sweet karolina] 26/5/2016 11:45

Q12,

The next set of Terpenetech numbers will be to 31 Jul 16 but won't actually be published until Apr 17.

The questions that all the ostriches ducked however can be answered from the numbers produced this April:

Cash in bank at 31 Jul 15: £8,106

How could they afford to pay £600k 4 weeks later? They got a loan, probably from a related party. They sold the shares Eden gave them to repay the loan with a nice fat fee.

NAV at 31 Jul 15 was MINUS £2,395

How can a value of over £3m be justified? It can't! The company is a POS that has never generated any real cash and does not have the resources that would be needed to do anything with the licence it "bought". Of course the pensioner muggers (WH Ireland) who signed off on the deal as Nomad who were also heavily fined by FCA and who failed to ensure that Oxford Capital were revealed as a related party when they converted their loan to Eden with a 100% fee and then sold all the shares without submitting TR1s managed to find some unnamed independent party to sign off on it. I note there was a £30k share issue fee also paid by Eden. Was that the sweetener to get the independent party aided and abetted by the pensioner muggers to sign off on what was clearly a fraudulent transaction?

The Terpenetech annual return due by 10 Aug 16 will be interesting considering the complete mess they have made of the 29.9% issue to Eden.

PS Nice article on the pensioner fighting back against the pensioner muggers who enabled the FRAUD at EDEN:

[hillofwad] 26/5/2016 10:50

Maybe TW is suffering from hiraeth

[quazie12] 26/5/2016 10:43

It's now getting on two months since the Greek shipment went out, now I am sure one thing management are doing is keeping in touch with their partners so wonder when that info will be relayed to shareholders ?Look forward to the next set of Terpenetech financials being lodged at companies house this summer. Then we can find out exactly how much "progress" has been made to justify the 29.9% strategic stake that Eden acquired.Wonder how many Eden shares they will have on the balance sheet ?

[quazie12] 26/5/2016 10:24

GemNo anger whatsoever on my part, are you referring to some of your over invested buddies on the other hand ? What exactly is your agenda ? Some sort of ostrich police, trying to protect them from the real world of facts and logic ?

[supersonico] 26/5/2016 10:18

I think both SK and q12 are willyfroths Jehovah witnesses. They are not deterred from asking me questions even when I post limericks in Welsh.. they are Hardcore

[gemstar2] 26/5/2016 09:54

Lot of anger there

Have you considered hypnotherapy?

[quazie12] 26/5/2016 09:28

Gemstar2There you go again. It really is too funny."are you xyz who used to post on ..... ?Get a life chief, if you spent 5 minutes longer looking at the facts of the company you're are allegedly invested in instead of who might be who and what they said.Is SK Tom W. Really ?!!Typical Troll like behaviours and furthermore totally embarrassing if you are in fact a grown adult allegedly on here to discuss your investment thoughts/opinions.You are either someone's puppet or barking. No credibility.Q12

[supersonico] 26/5/2016 09:26

Roeddwn yn teimlo diwydrwydd dyladwy a gynhaliwyd gan gwmni a oedd llai o obsesiwn ar mens gwaelodion a hen Vendettas dyn yn ei naratif yn debygol o fod yn fwy gwrthrychol ac yn ffrwythlon i mi fel buddsoddwr.

[gemstar2] 26/5/2016 09:10

Quazzie, are you Big Al who used to post on iii?

[hillofwad] 25/5/2016 20:09

Efallai bod y bwrdd yn dawel ond mae'r hwyaid yn mynd fel y diawl!

[sweet karolina] 25/5/2016 18:40

Oh look loveprat is back. Does he have something interesting to say about the results? Maybe he has answered the questions BOF ducked. Shall I unfilter him to find out? Nah what's the point a leopard does not change its spots and loveprat will always be a complete tool with nothing relevant to say.

[supersonico] 25/5/2016 18:25

yn union fel yr hen amser

[loverat] 25/5/2016 18:11

I note that SK has not been apprehended by the Tasmanian authorities yet. Unless of course they allow the internet in prison?

I thought the recent relative quiet might have meant someone had sued/prosecuted him.

Perhaps he has been busy reading up on the law since his last posts on the subject were exposed as nonsense.

[sweet karolina] 25/5/2016 17:59

How about answering the questions BOF, what are you scared of?

[supersonico] 25/5/2016 17:31

Frothy can you do another manonman cast someone bought £25k on the strength of it.

Persuasive

[the prophet] 25/5/2016 17:02

thanks, LR2

interesting as well to look at the forecast t/o that Shore Capital are predicting for this year and next

2106 t/o £1.7m

2017 t/o £3.2m

As overheads are pretty low, it doesn't take too much income for Eden to be seriously profitable, as can be seen from the 2017 forecasts.

Whilst it is very encouraging to see real commercial traction from Eden the value surely lies in Eden's IP, patents and approvals.
This interview is a few years old, but the information is just a valid now



The cost of registering a biopesticide active ingredient is estimated at $20m per ingredient, and Eden have EU approval for three such ingredients. Thats a base cost of $60m with no allowance for the time it takes or the market penetration such approved and tested products can give you. A traditional chemical is estimated to cost $250m to get approved!

Interesting to note that the interview suggests it is easier to for companies to acquire other companies that have the relevant approvals of new products rather than starting from ground zero, which takes years and years and a lot of money.I can see Eden being taken out at some point , hopefully for a hefty sum, there are plenty of precedents in the agri biotech market.

imo, Eden has very valuable IP and patents and approvals. Clearly this is also recognised by Intellectual ventures, a leading US company in the field of IP.

Shore Capital had this to say on this aspect, note IV is committing it's own capital in helping develop Eden's IP:

Protecting and developing Eden’s IP

Eden is an IP-led business so we believe one of the important developments during the year was management signing a collaboration and licence agreement with Intellectual Ventures (‘IV’) in September 2015. The agreement provides Eden with access to IV’s leading IP-related services including its network of licencing and business development professionals. IV is said to be committing capital to the further protection and development of Eden’s patent portfolio with its return aligned to the development of Eden’s business going forward

[sweet karolina] 25/5/2016 16:41

Q12 the fact that the company has so little faith in its own forecasts of profits that they have have not recognised any tax losses tells you all you really need to know.

However this bit from Note 8 of the results is also interesting:

- The projected market sizes for the key products which the Company is developing. These include a projected market of $214m for 3AEY, $100m for Powdery Mildew, and $296m for nematodes.

- The projected market share attainable by the Company. In preparing the valuation, a base projected market share growing to 5% of the relevant markets has been assumed.

- As the nature of the Company's revenue streams are a mixture of milestone payments, licence income and royalties, there are no specific projected growth rates used - the timing of the attainment of the milestones which are attainable on project by project basis is a key assumption in the forecasts.

- The discounted cash flows have assumed a discount factor of 9%.

So far they only have some approvals for 3 AEY the rest of it is jam tomorrow. However what they are saying is one day in the distant future they think they may get a 5% market share of a $610m market. Great that is $31M gross sales. Which puts net sales at around $15m and Eden gets a 10% royalty on net sales so $1.5m or about £1m per year which is just about enough to pay admin costs. Yep they have no need of those tax losses as their own estimates are they will never generate a pre tax profit.

[quazie12] 25/5/2016 16:20

What's that Super ? Shore Cap still reiterating 24p ?? share price 10p. ROFL

[supersonico] 25/5/2016 16:13

C12 Rydych yn bell RHY ddiflas ar gyfer y bwrdd hwn.

[quazie12] 25/5/2016 16:12

Wow ! I see Shore Capital are bullish on Eden's turnaround already, forecasting £500k EBITDA by 31/12/16. From eroding cash balances pre placing, we know the company were still losing money until very recently so what does that forecast really mean ? Let's assume conservatively that Eden lost £250k first 3 months to 31/3/16 based on £1.1m loss PY), and placing costs were say £250k, that means they need to make over £1m in 9 months from 1/4/16 to 31/12/16, annualised that's £1.3m or over £100k profit per month every month til Christmas ! Where are the RNS's then ?